Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells

BACKGROUND: Components of the microenvironment such as bone marrow stromal cells (BMSCs) are well known to support multiple myeloma (MM) disease progression and resistance to chemotherapy including the proteasome inhibitor bortezomib. However, functional distinctions between BMSCs in MM patients and...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Markovina, Stephanie, Callander, Natalie S, O'Connor, Shelby L, Xu, Guangwu, Shi, Yufang, Leith, Catherine P, Kim, KyungMann, Trivedi, Parul, Kim, Jaehyup, Hematti, Peiman, Miyamoto, Shigeki
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2010
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3095250/
https://ncbi.nlm.nih.gov/pubmed/20604947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-9-176
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items